Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-03

Clinical Trial Update: Safety and Performance of Dafodil Heart Valves in Real-World Aortic and Mitral Valve Replacement

View source ↗

Summary

Clinical trial update on the safety and performance of Dafodil Heart Valves for aortic and mitral valve replacement; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Dafodil Heart Valves

Snippet

Sponsor: Meril Life Sciences Pvt. Ltd. | Conditions: Aortic Valve Disease, Mitral Valve Disease, Prosthetic Heart Valve Dysfunction, Valvular Heart Disease Requiring Surgical Aortic or Mitral Valve Replacement | Status: NOT_YET_RECRUITING